| Product Code: ETC7647218 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cancer Therapeutics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cancer Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cancer Therapeutics Market - Industry Life Cycle |
3.4 Israel Cancer Therapeutics Market - Porter's Five Forces |
3.5 Israel Cancer Therapeutics Market Revenues & Volume Share, By APPLICATION, 2021 & 2031F |
3.6 Israel Cancer Therapeutics Market Revenues & Volume Share, By TOP SELLING DRUGS, 2021 & 2031F |
4 Israel Cancer Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Technological advancements in cancer therapeutics |
4.2.3 Growing investments in research and development for cancer treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals |
4.3.2 High cost associated with cancer therapeutics |
4.3.3 Limited accessibility to advanced cancer treatments in certain regions of Israel |
5 Israel Cancer Therapeutics Market Trends |
6 Israel Cancer Therapeutics Market, By Types |
6.1 Israel Cancer Therapeutics Market, By APPLICATION |
6.1.1 Overview and Analysis |
6.1.2 Israel Cancer Therapeutics Market Revenues & Volume, By APPLICATION, 2021- 2031F |
6.1.3 Israel Cancer Therapeutics Market Revenues & Volume, By Blood cancer, 2021- 2031F |
6.1.4 Israel Cancer Therapeutics Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.1.5 Israel Cancer Therapeutics Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.1.6 Israel Cancer Therapeutics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 Israel Cancer Therapeutics Market Revenues & Volume, By Head and Neck Cancer, 2021- 2031F |
6.1.8 Israel Cancer Therapeutics Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.1.9 Israel Cancer Therapeutics Market Revenues & Volume, By Mesothelioma, 2021- 2031F |
6.1.10 Israel Cancer Therapeutics Market Revenues & Volume, By Mesothelioma, 2021- 2031F |
6.2 Israel Cancer Therapeutics Market, By TOP SELLING DRUGS |
6.2.1 Overview and Analysis |
6.2.2 Israel Cancer Therapeutics Market Revenues & Volume, By Revlimid, 2021- 2031F |
6.2.3 Israel Cancer Therapeutics Market Revenues & Volume, By Avastin, 2021- 2031F |
6.2.4 Israel Cancer Therapeutics Market Revenues & Volume, By Herceptin, 2021- 2031F |
6.2.5 Israel Cancer Therapeutics Market Revenues & Volume, By Rituxan, 2021- 2031F |
6.2.6 Israel Cancer Therapeutics Market Revenues & Volume, By Opdivo, 2021- 2031F |
6.2.7 Israel Cancer Therapeutics Market Revenues & Volume, By Gleevec, 2021- 2031F |
6.2.8 Israel Cancer Therapeutics Market Revenues & Volume, By Imbruvica, 2021- 2031F |
6.2.9 Israel Cancer Therapeutics Market Revenues & Volume, By Imbruvica, 2021- 2031F |
7 Israel Cancer Therapeutics Market Import-Export Trade Statistics |
7.1 Israel Cancer Therapeutics Market Export to Major Countries |
7.2 Israel Cancer Therapeutics Market Imports from Major Countries |
8 Israel Cancer Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for cancer therapeutics in Israel |
8.2 Percentage of cancer patients receiving targeted therapy or immunotherapy |
8.3 Adoption rate of precision medicine approaches in cancer treatment in Israel |
9 Israel Cancer Therapeutics Market - Opportunity Assessment |
9.1 Israel Cancer Therapeutics Market Opportunity Assessment, By APPLICATION, 2021 & 2031F |
9.2 Israel Cancer Therapeutics Market Opportunity Assessment, By TOP SELLING DRUGS, 2021 & 2031F |
10 Israel Cancer Therapeutics Market - Competitive Landscape |
10.1 Israel Cancer Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Israel Cancer Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here